226 related articles for article (PubMed ID: 21119367)
1. Expression of p53, Ki-67, and CD31 proteins in endometrial polyps of postmenopausal women treated with tamoxifen.
Miranda SP; Traiman P; Cândido EB; Lages EL; Freitas GF; Lamaita RM; Vidigal PV; da Silva Filho AL
Int J Gynecol Cancer; 2010 Dec; 20(9):1525-30. PubMed ID: 21119367
[TBL] [Abstract][Full Text] [Related]
2. Expression of Bcl-2 and Ki-67 in tamoxifen-associated endometrial polyps: comparison with postmenopausal polyps.
Altaner S; Gucer F; Tokatli F; Guresci S; Ozdemir C; Puyan FO; Kutlu K
Onkologie; 2006 Sep; 29(8-9):376-80. PubMed ID: 16974115
[TBL] [Abstract][Full Text] [Related]
3. Expression of p53 protein in the endometrial polyp in postmenopausal women.
Neto LC; Soares JM; Giusa-Chiferi MG; Gonçalves WJ; Baracat EC
Eur J Gynaecol Oncol; 2013; 34(6):509-12. PubMed ID: 24601040
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
6. The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium.
Mourits MJ; Ten Hoor KA; van der Zee AG; Willemse PH; de Vries EG; Hollema H
J Clin Pathol; 2002 Jul; 55(7):514-9. PubMed ID: 12101196
[TBL] [Abstract][Full Text] [Related]
7. Is the immunohistochemical expression of proliferation (Ki-67) and apoptosis (Bcl-2) markers and cyclooxigenase-2 (COX-2) related to carcinogenesis in postmenopausal endometrial polyps?
Antunes A; Andrade LA; Pinto GA; Leão R; Pinto-Neto AM; Costa-Paiva L
Anal Quant Cytopathol Histpathol; 2012 Oct; 34(5):264-72. PubMed ID: 23301386
[TBL] [Abstract][Full Text] [Related]
8. Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen.
McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
Maturitas; 2006 Jun; 54(3):252-9. PubMed ID: 16413707
[TBL] [Abstract][Full Text] [Related]
9. Proliferation in Postmenopausal Endometrial Polyps-A Potential for Malignant Transformation.
Adomaitienė L; Nadišauskienė R; Nickkho-Amiry M; Čižauskas A; Palubinskienė J; Holland C; Seif MW
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31466367
[No Abstract] [Full Text] [Related]
10. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
Cheng WF; Lin HH; Torng PL; Huang SC
Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
[TBL] [Abstract][Full Text] [Related]
11. Expression of p53 in endometrial polyps with special reference to the p53 signature.
Sho T; Hachisuga T; Kawagoe T; Urabe R; Kurita T; Kagami S; Shimajiri S; Fujino Y
Histol Histopathol; 2016 Jul; 31(7):751-8. PubMed ID: 26727623
[TBL] [Abstract][Full Text] [Related]
12. [Expression of hormonal receptors (alpha-estrogen, beta-estrogen, progesteron), Ki-67 and P53 in endometrium of tamoxifen treated breast cancer patients].
Negoiţă M; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):834-8. PubMed ID: 22046795
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of p53 in the endometrial gland in postmenopausal women.
Koi C; Hachisuga T; Murakami M; Kurita T; Nguyen TT; Shimajiri S; Fujino Y
Menopause; 2015 Jan; 22(1):104-7. PubMed ID: 24893067
[TBL] [Abstract][Full Text] [Related]
14. Modulation of endometrial steroid receptors and growth regulatory genes by tamoxifen.
Elkas J; Armstrong A; Pohl J; Cuttitta F; Martínez A; Gray K
Obstet Gynecol; 2000 May; 95(5):697-703. PubMed ID: 10775732
[TBL] [Abstract][Full Text] [Related]
15. Survivin Expression in Simple Endometrial Polyps and Tamoxifen-associated Endometrial Polyps.
Gokmen Karasu AF; Sonmez FC; Aydin S; Adanir I; Marasli M; Ilhan GK
Int J Gynecol Pathol; 2018 Jan; 37(1):27-31. PubMed ID: 28319569
[TBL] [Abstract][Full Text] [Related]
16. The utility of endometrial thickness measurement in asymptomatic postmenopausal women with endometrial fluid.
Seckin B; Ozgu-Erdinc AS; Dogan M; Turker M; Cicek MN
J Obstet Gynaecol; 2016; 36(2):230-3. PubMed ID: 26467302
[TBL] [Abstract][Full Text] [Related]
17. L-type amino acid transporter 1 expression increases in well-differentiated but decreases in poorly differentiated endometrial endometrioid adenocarcinoma and shows an inverse correlation with p53 expression.
Watanabe J; Yokoyama Y; Futagami M; Mizunuma H; Yoshioka H; Washiya K; Hana K; Endou H; Okayasu I
Int J Gynecol Cancer; 2014 May; 24(4):659-63. PubMed ID: 24694899
[TBL] [Abstract][Full Text] [Related]
18. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen.
Lahti E; Vuopala S; Kauppila A; Blanco G; Ruokonen A; Laatikainen T
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781
[TBL] [Abstract][Full Text] [Related]
19. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
[TBL] [Abstract][Full Text] [Related]
20. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
